![Julio Font](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Font
Director Ejecutivo en Noray Bioinformatics SL .
Perfil
Julio Font is the founder and former Chief Executive Officer of Noray Bioinformatics SL, a company he founded in 2002.
He is currently the Chief Executive Officer of Histocell SL.
Cargos activos de Julio Font
Empresas | Cargo | Inicio |
---|---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Director Ejecutivo | 21/10/2002 |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Noray Bioinformatics SL
![]() Noray Bioinformatics SL Packaged SoftwareTechnology Services Noray Bioinformatics SL develops software products for the biosciences sector. It offers support to the biosciences sector: Biotechnology, Biomedicine, and Bipharmacy. The company was founded by Julio Font in 2002 and is headquartered in Derio, Spain. | Technology Services |
Histocell SL
![]() Histocell SL BiotechnologyHealth Technology Histocell SL manufactures and develops cell therapy drugs. The firm specializes in the development of cell therapy drugs that treat conditions such as spinal cord injuries, idiopathic pulmonary fibrosis, scar tissue defects, and dermo-epidermal deficiencies. Its service portfolio encompasses cell therapy services for clinical applications, molecular and cellular biology analysis, biocompatibility tests, and biological research. The company was founded in 2004 and is headquartered in Derio, Spain. | Health Technology |
- Bolsa de valores
- Insiders
- Julio Font